dự phòng viêm nội tâm mạc nhiễm khuẩn
Patient Category | Drug/Dosage | Time in Relation to Procedure |
Dental/Oral/Respiratory Tract or Esophageal Procedures | ||
Oral Penicillin tolerant | Amoxicillin 2 g PO | 1 h preprocedure |
Penicillin allergic | Azithromycin or Clarithromycin 500 mg POor Clindamycin 600 mg PO or Cephalexin or Cefadroxil 2.0 g | 1 h preprocedure 1 h preprocedure 1 h preprocedure |
Parenteral Penicillin tolerant | Ampicillin 2.0 g IV/IM | Within 30 min preprocedure |
Penicillin allergic | Vancomycin 1.0 g or Clindamycin 600 mg IV or Cefazolin 1.0 g | Slowly over 1 h starting preprocedure Within 30 min preprocedure Within 30 min preprocedure |
Genitourinary or Gastrointestinal (Excluding Esophageal) Procedures | ||
Parenteral High Riska Penicillin tolerant | Ampicillin 2 g IV/IM + gentamicin 1.5 mg/kg IV/IM (not to exceed 120 mg) followed 6 h later by Ampicillin 1 g IV/IM or Amoxicillin 1 g PO | Within 30 min preprocedure and follow-up 6 h post 1st dose |
Penicillin allergic | Vancomycin 1 g IV over 1-2 h + gentamicin 1.5 mg/kg IV (not to exceed 120 mg)—complete infusions within 30 min of starting procedure | Complete within 30 min preprocedure |
Parenteral Moderate Risk | ||
Penicillin tolerant | Ampicillin 2 g IV/IM | Within 30 min preprocedure |
Penicillin allergic | Vancomycin 1 g IV over 1-2 h | Within 30 min preprocedure |
Oral Moderate Risk | Amoxicillin 2 g PO | 1 h preprocedure |
IM, intramuscular, IV, intravenous; PO, by mouth aHigh risk: prosthetic valve, history of endocarditis, surgically constructed systemic/pulmonary shunts or conduits (Adapted from Dajani AS et al. Prevention of bacterial endocarditis: recommendations by the American Heart Association. JAMA 1997;277:1794-1801.) |